ChemSpider 2D Image | Amerge | C17H26ClN3O2S

Amerge

  • Molecular FormulaC17H26ClN3O2S
  • Average mass371.925 Da
  • Monoisotopic mass371.143433 Da
  • ChemSpider ID54857

More details:






Validated by Experts, Validated by Users, Non-Validated, Removed by Users

10X8X4P12Z
143388-64-1 [RN]
1H-Indole-5-ethanesulfonamide, N-methyl-3-(1-methyl-4-piperidinyl)-, hydrochloride (1:1) [ACD/Index Name]
Amerge [Trade name] [Wiki]
GR-85548A
MFCD08141821
naramig
Naratriptan (hydrochloride)
Naratriptan Hydrochloride
Naratriptan monohydrochloride
More...

Validated by Experts, Validated by Users, Non-Validated, Removed by Users

121679-13-8 , 143388-64-1 [DBID]
D00674 [DBID]
GG-548 [DBID]
GR-85548 [DBID]
LS-172502 [DBID]
  • Experimental Physico-chemical Properties
  • Miscellaneous
    • Bio Activity:

      5-HT Receptor MedChem Express HY-B0197A
      GPCR/G protein MedChem Express HY-B0197A
      GPCR/G protein; Neuronal Signaling; MedChem Express HY-B0197A
      Naratriptan hydrochloride is a selective 5-HT1 receptor subtype agonist and is a triptan drug that is used for the treatment of migraine headaches. MedChem Express
      Naratriptan hydrochloride is a selective 5-HT1 receptor subtype agonist and is a triptan drug that is used for the treatment of migraine headaches.; Target: 5-HT1 Receptor; Naratriptan is a triptan drug marketed by GlaxoSmithKline and is used for the treatment of migraine headaches. MedChem Express HY-B0197A
      Naratriptan hydrochloride is a selective 5-HT1 receptor subtype agonist and is a triptan drug that is used for the treatment of migraine headaches.;Target: 5-HT1 ReceptorNaratriptan is a triptan drug marketed by GlaxoSmithKline and is used for the treatment of migraine headaches. Naratriptan is available in 2.5 mg tablets. It is a selective 5-HT1 receptor subtype agonist. Naratriptan is used for the treatment of the acute migraine attacks and the symptoms of migraine, including severe, throbbing headaches that sometimes are accompanied by nausea and sensitivity to sound or light.;The causes of migraine are not clearly understood; however, the efficacy of naratriptans and other triptans is believed to be due to their activity as 5HT (serotonin) agonists.A meta-analysis of 53 clinical trials has shown that all triptans are effective for treating migraine at marketed doses and that naratriptan, although less effective than sumatriptan and rizatriptan was more effective than placebo MedChem Express HY-B0197A

Predicted data is generated using the ACD/Labs Percepta Platform - PhysChem Module, version: 14.00

No predicted properties have been calculated for this compound.

Click to predict properties on the Chemicalize site






Advertisement